Diabetes Care Devices Global Market Report 2018 Including: Blood Glucose Test Strips; Insulin Pens; Insulin Syringes; Insulin Pumps and injectors; Lancing Devices; Continuous Glucose Monitoring Devices; Blood Glucose Meters Covering: Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company
Feb 2018
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Scope Markets Covered: Blood Glucose Test Strips; Insulin Pens; Insulin Syringes; Insulin Pumps and injectors; Lancing Devices; Continuous Glucose Monitoring Devices; Blood Glucose Meters Companies Mentioned: Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa. Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Diabetes Care Devices Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Diabetes Care Devices Market Characteristics The diabetes care devices industry manufactures blood glucose monitoring devices and insulin delivery devices. Diabetes care devices are designed to diagnose, monitor or manage type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. The diabetes care devices market in this report is segmented into blood glucose test strips, insulin pens, insulin syringes, insulin pumps and injectors, lancing devices, continuous glucose monitoring devices and blood glucose meters. Blood glucose test strips are used to Insulin pens are reusable pen like tools used to Insulin Syringes are the reusable devices used to Insulin Pumps and Injectors are the devices with which insulin can be Lancing Devices are used to prick the skin to Continuous Glucose Monitoring Devices are devices which are Blood Glucose Meters are the devices which are In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.
Diabetes Care Devices Market Historic Growth The global diabetes care devices market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global diabetes care devices market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:
Diabetes Care Devices Market Forecast Growth The global diabetes care devices market is expected to grow from $XX billion in 2017 to $16 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global diabetes care devices market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:
Diabetes Care Devices Market Segmentation The chart and table below shows the split of the diabetes care devices market in 2017.
The total market value for diabetes care devices was $X billion in 2017. The markets that are covered include Blood Glucose Test Strips; Insulin Pens; Insulin Syringes; Insulin Pumps and injectors; Lancing Devices; Continuous Glucose Monitoring Devices; Blood Glucose Meters. Blood Glucose Test Strips was the X largest segment in the diabetes care devices market with X% share of the market. The market value for the blood glucose test strips was $X billion in 2017. Insulin Pens made up around X% share of the market. The market value for the insulin pens was $X billion in 2017.
Diabetes Care Devices Market Regional And Country Analysis The Asia Pacific was the largest region in the diabetes care devices market in 2017, diabetes care devices for $X billion or X% market share. North America was the x largest region diabetes care devices for $X billion or X% market share. Western Europe was the x largest region diabetes care devices for $X billion or X% market share.
Diabetes Care Devices Market Competitive Landscape The leading competitors in the global diabetes care devices market are Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company. The chart and table below displays the percentage market share of the top players in the diabetes care devices market industry.
Roche generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Medtronic generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. J&J generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Abbott generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Becton, Dickinson and Company generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Company Profile Roche Overview Roche was the largest company in the global diabetes care devices market with XX% market share in 2017. Roche was founded in 1896 and is headquartered in Switzerland. It had about 88,000 employees working across more than 150 countries. Products and Services Roche classifies its businesses into two reportable divisions – The Pharmaceuticals division of the company focuses on The Diagnostics division of the company caters to Strategy Roche’s key strategy is to serve patients across the healthcare spectrum, with emphasis on clinical chemistry, tissue diagnostics, and molecular diagnostics. The company invests approximately CHF 9 billion in research and development every year, Financial Performance Roche generated revenue of CHF XX billion ($XX billion) in the financial year 2016. The company had a market Medtronic Overview Products and Services Strategy Financial Performance
J&J Overview Products and Services Strategy Financial Performance
Abbott Overview Products and Services Strategy Financial Performance
Becton, Dickinson and Company Overview Products and Services Strategy Financial Performance